Rank | Gene Set | Z-score |
---|---|---|
1 | daunorubicin metabolic process (GO:0044597) | 8.41072077 |
2 | polyketide metabolic process (GO:0030638) | 8.41072077 |
3 | doxorubicin metabolic process (GO:0044598) | 8.41072077 |
4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.89813819 |
5 | coenzyme catabolic process (GO:0009109) | 5.49066067 |
6 | L-phenylalanine catabolic process (GO:0006559) | 5.11542439 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.11542439 |
8 | biotin metabolic process (GO:0006768) | 4.95804601 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.80500075 |
10 | L-phenylalanine metabolic process (GO:0006558) | 4.80500075 |
11 | valine metabolic process (GO:0006573) | 4.77151809 |
12 | aromatic amino acid family catabolic process (GO:0009074) | 4.69147286 |
13 | sulfur amino acid catabolic process (GO:0000098) | 4.65756847 |
14 | tryptophan catabolic process (GO:0006569) | 4.30889296 |
15 | indole-containing compound catabolic process (GO:0042436) | 4.30889296 |
16 | indolalkylamine catabolic process (GO:0046218) | 4.30889296 |
17 | cellular modified amino acid catabolic process (GO:0042219) | 4.27580801 |
18 | tryptophan metabolic process (GO:0006568) | 4.25025348 |
19 | behavioral response to nicotine (GO:0035095) | 4.23699874 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.08583804 |
21 | branched-chain amino acid catabolic process (GO:0009083) | 4.04516881 |
22 | hormone catabolic process (GO:0042447) | 3.94044061 |
23 | DNA deamination (GO:0045006) | 3.90565762 |
24 | branched-chain amino acid metabolic process (GO:0009081) | 3.85822284 |
25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.81035514 |
26 | interkinetic nuclear migration (GO:0022027) | 3.76254874 |
27 | cytidine metabolic process (GO:0046087) | 3.74594540 |
28 | cytidine catabolic process (GO:0006216) | 3.74594540 |
29 | cytidine deamination (GO:0009972) | 3.74594540 |
30 | kynurenine metabolic process (GO:0070189) | 3.74132430 |
31 | cofactor catabolic process (GO:0051187) | 3.68350750 |
32 | fatty acid beta-oxidation (GO:0006635) | 3.67594696 |
33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.65710842 |
34 | bile acid biosynthetic process (GO:0006699) | 3.63683020 |
35 | quinone metabolic process (GO:1901661) | 3.60885873 |
36 | glyoxylate metabolic process (GO:0046487) | 3.54109689 |
37 | response to dietary excess (GO:0002021) | 3.52120945 |
38 | epoxygenase P450 pathway (GO:0019373) | 3.50737862 |
39 | drug metabolic process (GO:0017144) | 3.49731147 |
40 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.48169362 |
41 | fatty acid oxidation (GO:0019395) | 3.47416490 |
42 | regulation of triglyceride catabolic process (GO:0010896) | 3.46739426 |
43 | regulation of sequestering of triglyceride (GO:0010889) | 3.42046776 |
44 | regulation of germinal center formation (GO:0002634) | 3.40138022 |
45 | lipid oxidation (GO:0034440) | 3.39703374 |
46 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.39689715 |
47 | response to lipoprotein particle (GO:0055094) | 3.37479973 |
48 | positive regulation of fatty acid oxidation (GO:0046321) | 3.35811051 |
49 | aromatic amino acid family metabolic process (GO:0009072) | 3.34653249 |
50 | fatty acid catabolic process (GO:0009062) | 3.33229834 |
51 | amino-acid betaine metabolic process (GO:0006577) | 3.30364134 |
52 | urea metabolic process (GO:0019627) | 3.30164786 |
53 | urea cycle (GO:0000050) | 3.30164786 |
54 | cellular response to exogenous dsRNA (GO:0071360) | 3.29456929 |
55 | acylglycerol homeostasis (GO:0055090) | 3.29038845 |
56 | triglyceride homeostasis (GO:0070328) | 3.29038845 |
57 | tyrosine metabolic process (GO:0006570) | 3.28845927 |
58 | bile acid metabolic process (GO:0008206) | 3.27079252 |
59 | short-chain fatty acid metabolic process (GO:0046459) | 3.23965391 |
60 | phenol-containing compound catabolic process (GO:0019336) | 3.23597168 |
61 | indolalkylamine metabolic process (GO:0006586) | 3.22874005 |
62 | cellular biogenic amine catabolic process (GO:0042402) | 3.22604614 |
63 | amine catabolic process (GO:0009310) | 3.22604614 |
64 | cysteine metabolic process (GO:0006534) | 3.21937121 |
65 | interferon-gamma production (GO:0032609) | 3.21611085 |
66 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.19150587 |
67 | cellular amino acid catabolic process (GO:0009063) | 3.16180060 |
68 | alpha-amino acid catabolic process (GO:1901606) | 3.13659878 |
69 | complement activation, alternative pathway (GO:0006957) | 3.13502540 |
70 | somite development (GO:0061053) | 3.13111154 |
71 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.12081721 |
72 | sulfation (GO:0051923) | 3.10022447 |
73 | heme transport (GO:0015886) | 3.09514447 |
74 | nucleoside transmembrane transport (GO:1901642) | 3.07980590 |
75 | monocarboxylic acid catabolic process (GO:0072329) | 3.07611500 |
76 | negative regulation of lipase activity (GO:0060192) | 3.07260445 |
77 | nitrogen cycle metabolic process (GO:0071941) | 3.06396944 |
78 | protein carboxylation (GO:0018214) | 3.06295879 |
79 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.06295879 |
80 | negative regulation of mast cell activation (GO:0033004) | 3.05642446 |
81 | organic acid catabolic process (GO:0016054) | 3.05061403 |
82 | carboxylic acid catabolic process (GO:0046395) | 3.05061403 |
83 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02204534 |
84 | somite rostral/caudal axis specification (GO:0032525) | 3.01408298 |
85 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.98987598 |
86 | primary alcohol catabolic process (GO:0034310) | 2.98658315 |
87 | activated T cell proliferation (GO:0050798) | 2.98088579 |
88 | maintenance of protein location in nucleus (GO:0051457) | 2.93826326 |
89 | carnitine metabolic process (GO:0009437) | 2.93384022 |
90 | acetyl-CoA metabolic process (GO:0006084) | 2.93328737 |
91 | regulation of protein activation cascade (GO:2000257) | 2.90530020 |
92 | prostate gland growth (GO:0060736) | 2.90297266 |
93 | homocysteine metabolic process (GO:0050667) | 2.87303725 |
94 | flavonoid metabolic process (GO:0009812) | 2.86105691 |
95 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.84363625 |
96 | phenylpropanoid metabolic process (GO:0009698) | 2.84271286 |
97 | protein polyglutamylation (GO:0018095) | 2.83924639 |
98 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.83724092 |
99 | diterpenoid biosynthetic process (GO:0016102) | 2.82107930 |
100 | piRNA metabolic process (GO:0034587) | 2.81781431 |
101 | serine family amino acid catabolic process (GO:0009071) | 2.80347040 |
102 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.79958041 |
103 | detection of light stimulus involved in visual perception (GO:0050908) | 2.79958041 |
104 | omega-hydroxylase P450 pathway (GO:0097267) | 2.79647761 |
105 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.79582491 |
106 | xenobiotic catabolic process (GO:0042178) | 2.79581688 |
107 | fatty acid transmembrane transport (GO:1902001) | 2.79260135 |
108 | very long-chain fatty acid metabolic process (GO:0000038) | 2.76897566 |
109 | cellular ketone metabolic process (GO:0042180) | 2.76588325 |
110 | imidazole-containing compound metabolic process (GO:0052803) | 2.76285396 |
111 | drug transmembrane transport (GO:0006855) | 2.75611270 |
112 | positive regulation of defense response to virus by host (GO:0002230) | 2.75441196 |
113 | lysine catabolic process (GO:0006554) | 2.75214150 |
114 | lysine metabolic process (GO:0006553) | 2.75214150 |
115 | high-density lipoprotein particle remodeling (GO:0034375) | 2.75076248 |
116 | plasma lipoprotein particle clearance (GO:0034381) | 2.73557691 |
117 | L-fucose catabolic process (GO:0042355) | 2.73511005 |
118 | fucose catabolic process (GO:0019317) | 2.73511005 |
119 | L-fucose metabolic process (GO:0042354) | 2.73511005 |
120 | endoderm formation (GO:0001706) | 2.72810781 |
121 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.71815437 |
122 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.70570682 |
123 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.70174298 |
124 | transepithelial transport (GO:0070633) | 2.69978569 |
125 | regulation of complement activation (GO:0030449) | 2.69929070 |
126 | phospholipid efflux (GO:0033700) | 2.69118477 |
127 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.68274087 |
128 | NADH dehydrogenase complex assembly (GO:0010257) | 2.68274087 |
129 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.68274087 |
130 | bile acid and bile salt transport (GO:0015721) | 2.67019036 |
131 | ethanol oxidation (GO:0006069) | 2.66952389 |
132 | positive regulation of lipid catabolic process (GO:0050996) | 2.66949608 |
133 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62986154 |
134 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.61614771 |
135 | DNA methylation involved in gamete generation (GO:0043046) | 2.61157892 |
136 | neutrophil mediated immunity (GO:0002446) | 2.58892136 |
137 | cell proliferation in forebrain (GO:0021846) | 2.58435468 |
138 | response to caffeine (GO:0031000) | 2.56695511 |
139 | cellular response to ATP (GO:0071318) | 2.56044553 |
140 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.55112842 |
141 | rRNA catabolic process (GO:0016075) | 2.53691153 |
142 | adaptation of signaling pathway (GO:0023058) | 2.52467683 |
143 | B cell receptor signaling pathway (GO:0050853) | 2.52269299 |
144 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.52152019 |
145 | positive regulation of glomerulus development (GO:0090193) | 2.49479153 |
146 | indole-containing compound metabolic process (GO:0042430) | 2.47434517 |
147 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.47078136 |
148 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.46883006 |
149 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.42876853 |
150 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.42467225 |
151 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.42467225 |
152 | negative regulation of lipid storage (GO:0010888) | 2.41633517 |
153 | cellular extravasation (GO:0045123) | 2.41487110 |
154 | regulation of memory T cell differentiation (GO:0043380) | 2.40653020 |
155 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.40538205 |
156 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.40538205 |
157 | regulation of skeletal muscle contraction (GO:0014819) | 2.40228002 |
158 | microglial cell activation (GO:0001774) | 2.38819937 |
159 | regulation of gamma-delta T cell activation (GO:0046643) | 2.37652348 |
160 | drug catabolic process (GO:0042737) | 2.35924064 |
161 | platelet dense granule organization (GO:0060155) | 2.35516961 |
162 | cell wall macromolecule catabolic process (GO:0016998) | 2.34452341 |
163 | synapsis (GO:0007129) | 2.33894798 |
164 | positive regulation of mast cell activation (GO:0033005) | 2.33848601 |
165 | parturition (GO:0007567) | 2.33007873 |
166 | regulation of female receptivity (GO:0045924) | 2.32267536 |
167 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.32227157 |
168 | negative thymic T cell selection (GO:0045060) | 2.31550029 |
169 | regulation of mast cell activation (GO:0033003) | 2.31379556 |
170 | cardiovascular system development (GO:0072358) | 2.30761664 |
171 | negative T cell selection (GO:0043383) | 2.28707972 |
172 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.25332654 |
173 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.22215624 |
174 | positive regulation of fatty acid transport (GO:2000193) | 2.21196177 |
175 | epithelial cilium movement (GO:0003351) | 2.21191277 |
176 | negative regulation of acute inflammatory response (GO:0002674) | 2.21176648 |
177 | cellular response to lithium ion (GO:0071285) | 2.21026978 |
178 | cAMP catabolic process (GO:0006198) | 2.20869198 |
179 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.20768486 |
180 | establishment of protein localization to Golgi (GO:0072600) | 2.20624371 |
181 | positive regulation of phosphatase activity (GO:0010922) | 2.19885109 |
182 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.17709396 |
183 | multicellular organism reproduction (GO:0032504) | 2.17660732 |
184 | regulation of hippo signaling (GO:0035330) | 2.17512039 |
185 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.16510974 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.73376327 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.17898907 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.90689260 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.78992840 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47594095 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.12325604 |
7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.09293325 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.48021445 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.99087966 |
10 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.87012776 |
11 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.87012776 |
12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.87012776 |
13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.72533265 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.66552899 |
15 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64000337 |
16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.58197224 |
17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.47370302 |
18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.44280297 |
19 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.37671648 |
20 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.17312515 |
21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16790489 |
22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.13094362 |
23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09511391 |
24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09401363 |
25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.09284635 |
26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.06814817 |
27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06344774 |
28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89466387 |
29 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86207370 |
30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80708244 |
31 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.79581332 |
32 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.72715790 |
33 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63395114 |
34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58659816 |
35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54954967 |
36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53620268 |
37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52936281 |
38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.51512648 |
39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51066463 |
40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49469334 |
41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48105266 |
42 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.47645301 |
43 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47416133 |
44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.46499082 |
45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44967304 |
46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.44887496 |
47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44745944 |
48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43410129 |
49 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.43335501 |
50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42926453 |
51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40801972 |
52 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40255825 |
53 | EWS_26573619_Chip-Seq_HEK293_Human | 1.39392650 |
54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38927028 |
55 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38795879 |
56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.37437180 |
57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37085395 |
58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36073223 |
59 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.35266143 |
60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35095777 |
61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31803821 |
62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30347434 |
63 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29891490 |
64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28291125 |
65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27478017 |
66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.25676898 |
67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24944825 |
68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23834163 |
69 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23834163 |
70 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.22391564 |
71 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20939570 |
72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20554294 |
73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20155896 |
74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18894757 |
75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18359961 |
76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.18242179 |
77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18115690 |
78 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17388050 |
79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17094413 |
80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.15753137 |
81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15371401 |
82 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14772459 |
83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12029696 |
84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11413481 |
85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10233197 |
86 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10233197 |
87 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10082582 |
88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09489847 |
89 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.09348589 |
90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08720845 |
91 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08708289 |
92 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08605545 |
93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07925085 |
94 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07925085 |
95 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07769238 |
96 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07578032 |
97 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07521850 |
98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.06747182 |
99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06747016 |
100 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.06341838 |
101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06136737 |
102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05977412 |
103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05756086 |
104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05572778 |
105 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05546025 |
106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05366430 |
107 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05096486 |
108 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05096486 |
109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04177789 |
110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04087462 |
111 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03695306 |
112 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03690713 |
113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03583953 |
114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02851448 |
115 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.02143978 |
116 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02014454 |
117 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01974748 |
118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00990895 |
119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00925776 |
120 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00921844 |
121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00435055 |
122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.98903738 |
123 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98036449 |
124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97421941 |
125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95919608 |
126 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93972696 |
127 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.92987560 |
128 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91165431 |
129 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91088267 |
130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90959069 |
131 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.90451367 |
132 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.89394412 |
133 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89057073 |
134 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88197619 |
135 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87565501 |
136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87485162 |
137 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.87272315 |
138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.86296477 |
139 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84719116 |
140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84567823 |
141 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84249761 |
142 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.83989659 |
143 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.83290027 |
144 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.81587395 |
145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77808701 |
146 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76852104 |
147 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.75931443 |
148 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.75417999 |
149 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75405478 |
150 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75062982 |
151 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74671180 |
152 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74225412 |
153 | MYB_26560356_Chip-Seq_TH1_Human | 0.73877946 |
154 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73263694 |
155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.72667322 |
156 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71787485 |
157 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71650107 |
158 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71522032 |
159 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.71384029 |
160 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69788735 |
161 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.69630312 |
162 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69153147 |
163 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68890018 |
164 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.68313107 |
165 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.68118229 |
166 | GATA3_26560356_Chip-Seq_TH2_Human | 0.66952697 |
167 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.66767602 |
168 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.66641058 |
169 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.65850553 |
170 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.64248260 |
171 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64072845 |
172 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.63831277 |
173 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63742360 |
174 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.63665394 |
175 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.63508240 |
176 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.63238941 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.09101928 |
2 | MP0005360_urolithiasis | 4.44274445 |
3 | MP0005365_abnormal_bile_salt | 4.39604780 |
4 | MP0003011_delayed_dark_adaptation | 4.24265415 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.88008426 |
6 | MP0003646_muscle_fatigue | 3.70718862 |
7 | MP0000569_abnormal_digit_pigmentation | 3.55377854 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.29474920 |
9 | MP0002254_reproductive_system_inflammat | 3.26980630 |
10 | MP0003252_abnormal_bile_duct | 2.81192877 |
11 | MP0010329_abnormal_lipoprotein_level | 2.52049224 |
12 | MP0005075_abnormal_melanosome_morpholog | 2.45961156 |
13 | MP0005670_abnormal_white_adipose | 2.43185303 |
14 | MP0006292_abnormal_olfactory_placode | 2.43126569 |
15 | MP0005174_abnormal_tail_pigmentation | 2.42436584 |
16 | MP0008877_abnormal_DNA_methylation | 2.40608799 |
17 | MP0002102_abnormal_ear_morphology | 2.37957636 |
18 | MP0005646_abnormal_pituitary_gland | 2.34729428 |
19 | MP0003806_abnormal_nucleotide_metabolis | 2.32771299 |
20 | MP0004264_abnormal_extraembryonic_tissu | 2.28874372 |
21 | MP0000015_abnormal_ear_pigmentation | 2.17769380 |
22 | MP0004145_abnormal_muscle_electrophysio | 2.04254338 |
23 | MP0000013_abnormal_adipose_tissue | 1.92553396 |
24 | MP0005332_abnormal_amino_acid | 1.91873468 |
25 | MP0000609_abnormal_liver_physiology | 1.90689136 |
26 | MP0005451_abnormal_body_composition | 1.90565885 |
27 | MP0003183_abnormal_peptide_metabolism | 1.84152798 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.76450415 |
29 | MP0004381_abnormal_hair_follicle | 1.67250938 |
30 | MP0003195_calcinosis | 1.67072113 |
31 | MP0001485_abnormal_pinna_reflex | 1.65690528 |
32 | MP0004019_abnormal_vitamin_homeostasis | 1.63080295 |
33 | MP0003191_abnormal_cellular_cholesterol | 1.62446898 |
34 | MP0005319_abnormal_enzyme/_coenzyme | 1.61066336 |
35 | MP0001666_abnormal_nutrient_absorption | 1.60292877 |
36 | MP0004043_abnormal_pH_regulation | 1.58068324 |
37 | MP0003186_abnormal_redox_activity | 1.54736112 |
38 | MP0005666_abnormal_adipose_tissue | 1.52878590 |
39 | MP0002452_abnormal_antigen_presenting | 1.50199724 |
40 | MP0003868_abnormal_feces_composition | 1.49889846 |
41 | MP0002138_abnormal_hepatobiliary_system | 1.47504939 |
42 | MP0000372_irregular_coat_pigmentation | 1.45559377 |
43 | MP0004142_abnormal_muscle_tone | 1.41364165 |
44 | MP0000230_abnormal_systemic_arterial | 1.41021900 |
45 | MP0005551_abnormal_eye_electrophysiolog | 1.37308341 |
46 | MP0002332_abnormal_exercise_endurance | 1.37303112 |
47 | MP0006082_CNS_inflammation | 1.36956976 |
48 | MP0003172_abnormal_lysosome_physiology | 1.35529686 |
49 | MP0002876_abnormal_thyroid_physiology | 1.35501273 |
50 | MP0002971_abnormal_brown_adipose | 1.32947292 |
51 | MP0001764_abnormal_homeostasis | 1.32097093 |
52 | MP0005389_reproductive_system_phenotype | 1.31790538 |
53 | MP0001835_abnormal_antigen_presentation | 1.30897558 |
54 | MP0006035_abnormal_mitochondrial_morpho | 1.29536670 |
55 | MP0004185_abnormal_adipocyte_glucose | 1.29491025 |
56 | MP0006036_abnormal_mitochondrial_physio | 1.29153815 |
57 | MP0000383_abnormal_hair_follicle | 1.28950608 |
58 | MP0005387_immune_system_phenotype | 1.28832069 |
59 | MP0001790_abnormal_immune_system | 1.28832069 |
60 | MP0008872_abnormal_physiological_respon | 1.27438789 |
61 | MP0000678_abnormal_parathyroid_gland | 1.27253300 |
62 | MP0002160_abnormal_reproductive_system | 1.26870591 |
63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24896720 |
64 | MP0009697_abnormal_copulation | 1.24709466 |
65 | MP0002420_abnormal_adaptive_immunity | 1.24532325 |
66 | MP0009643_abnormal_urine_homeostasis | 1.23478944 |
67 | MP0001819_abnormal_immune_cell | 1.22999294 |
68 | MP0010386_abnormal_urinary_bladder | 1.21921755 |
69 | MP0002095_abnormal_skin_pigmentation | 1.21527576 |
70 | MP0002970_abnormal_white_adipose | 1.20787053 |
71 | MP0002277_abnormal_respiratory_mucosa | 1.20202238 |
72 | MP0005464_abnormal_platelet_physiology | 1.18336255 |
73 | MP0003724_increased_susceptibility_to | 1.16946586 |
74 | MP0002132_abnormal_respiratory_system | 1.14938051 |
75 | MP0001661_extended_life_span | 1.14161305 |
76 | MP0010368_abnormal_lymphatic_system | 1.14132537 |
77 | MP0003879_abnormal_hair_cell | 1.13986124 |
78 | MP0005083_abnormal_biliary_tract | 1.11917896 |
79 | MP0002419_abnormal_innate_immunity | 1.11857470 |
80 | MP0005334_abnormal_fat_pad | 1.10874986 |
81 | MP0003890_abnormal_embryonic-extraembry | 1.10186699 |
82 | MP0005671_abnormal_response_to | 1.09165608 |
83 | MP0004130_abnormal_muscle_cell | 1.08762876 |
84 | MP0009115_abnormal_fat_cell | 1.07345814 |
85 | MP0002148_abnormal_hypersensitivity_rea | 1.07310155 |
86 | MP0003950_abnormal_plasma_membrane | 1.05965764 |
87 | MP0001800_abnormal_humoral_immune | 1.02298497 |
88 | MP0000685_abnormal_immune_system | 1.01985136 |
89 | MP0002638_abnormal_pupillary_reflex | 1.01232823 |
90 | MP0002396_abnormal_hematopoietic_system | 1.00285409 |
91 | MP0008775_abnormal_heart_ventricle | 0.99908631 |
92 | MP0006072_abnormal_retinal_apoptosis | 0.99449161 |
93 | MP0005647_abnormal_sex_gland | 0.97555100 |
94 | MP0004484_altered_response_of | 0.97373698 |
95 | MP0003045_fibrosis | 0.97241608 |
96 | MP0008004_abnormal_stomach_pH | 0.96711053 |
97 | MP0005167_abnormal_blood-brain_barrier | 0.96073352 |
98 | MP0009764_decreased_sensitivity_to | 0.95600271 |
99 | MP0002078_abnormal_glucose_homeostasis | 0.94962442 |
100 | MP0008469_abnormal_protein_level | 0.92196755 |
101 | MP0000598_abnormal_liver_morphology | 0.91128719 |
102 | MP0003763_abnormal_thymus_physiology | 0.90785826 |
103 | MP0005253_abnormal_eye_physiology | 0.90665823 |
104 | MP0009763_increased_sensitivity_to | 0.88343443 |
105 | MP0000689_abnormal_spleen_morphology | 0.87546149 |
106 | MP0000516_abnormal_urinary_system | 0.85407117 |
107 | MP0005367_renal/urinary_system_phenotyp | 0.85407117 |
108 | MP0000749_muscle_degeneration | 0.85106763 |
109 | MP0000716_abnormal_immune_system | 0.84062797 |
110 | MP0004782_abnormal_surfactant_physiolog | 0.83268543 |
111 | MP0009046_muscle_twitch | 0.81527541 |
112 | MP0001986_abnormal_taste_sensitivity | 0.81082070 |
113 | MP0002405_respiratory_system_inflammati | 0.80464209 |
114 | MP0001845_abnormal_inflammatory_respons | 0.80157102 |
115 | MP0005266_abnormal_metabolism | 0.80068871 |
116 | MP0000427_abnormal_hair_cycle | 0.80001594 |
117 | MP0005375_adipose_tissue_phenotype | 0.79956846 |
118 | MP0001501_abnormal_sleep_pattern | 0.79400567 |
119 | MP0002837_dystrophic_cardiac_calcinosis | 0.78441698 |
120 | MP0004885_abnormal_endolymph | 0.77307229 |
121 | MP0005257_abnormal_intraocular_pressure | 0.77192777 |
122 | MP0000631_abnormal_neuroendocrine_gland | 0.76702088 |
123 | MP0008961_abnormal_basal_metabolism | 0.76526419 |
124 | MP0003656_abnormal_erythrocyte_physiolo | 0.75808380 |
125 | MP0005410_abnormal_fertilization | 0.75062389 |
126 | MP0005379_endocrine/exocrine_gland_phen | 0.74034195 |
127 | MP0001533_abnormal_skeleton_physiology | 0.73725870 |
128 | MP0005025_abnormal_response_to | 0.73552739 |
129 | MP0003787_abnormal_imprinting | 0.73358853 |
130 | MP0000470_abnormal_stomach_morphology | 0.72467797 |
131 | MP0003828_pulmonary_edema | 0.72462677 |
132 | MP0005376_homeostasis/metabolism_phenot | 0.72276959 |
133 | MP0001440_abnormal_grooming_behavior | 0.71237275 |
134 | MP0004036_abnormal_muscle_relaxation | 0.71115274 |
135 | MP0002398_abnormal_bone_marrow | 0.70928945 |
136 | MP0005535_abnormal_body_temperature | 0.69776711 |
137 | MP0001853_heart_inflammation | 0.69310411 |
138 | MP0004084_abnormal_cardiac_muscle | 0.68187465 |
139 | MP0009785_altered_susceptibility_to | 0.68088349 |
140 | MP0008995_early_reproductive_senescence | 0.67290862 |
141 | MP0005645_abnormal_hypothalamus_physiol | 0.66977553 |
142 | MP0002098_abnormal_vibrissa_morphology | 0.66877757 |
143 | MP0005000_abnormal_immune_tolerance | 0.65670832 |
144 | MP0009765_abnormal_xenobiotic_induced | 0.65540133 |
145 | MP0009840_abnormal_foam_cell | 0.65523902 |
146 | MP0002723_abnormal_immune_serum | 0.65454889 |
147 | MP0002127_abnormal_cardiovascular_syste | 0.65274124 |
148 | MP0005636_abnormal_mineral_homeostasis | 0.64598108 |
149 | MP0001968_abnormal_touch/_nociception | 0.64052227 |
150 | MP0002166_altered_tumor_susceptibility | 0.63864196 |
151 | MP0005310_abnormal_salivary_gland | 0.63820229 |
152 | MP0004147_increased_porphyrin_level | 0.63788517 |
153 | MP0009053_abnormal_anal_canal | 0.63626605 |
154 | MP0009642_abnormal_blood_homeostasis | 0.62887184 |
155 | MP0002928_abnormal_bile_duct | 0.62213545 |
156 | MP0000465_gastrointestinal_hemorrhage | 0.61766736 |
157 | MP0005499_abnormal_olfactory_system | 0.60767721 |
158 | MP0005394_taste/olfaction_phenotype | 0.60767721 |
159 | MP0005452_abnormal_adipose_tissue | 0.60332419 |
160 | MP0001243_abnormal_dermal_layer | 0.58595356 |
161 | MP0001324_abnormal_eye_pigmentation | 0.58060585 |
162 | MP0005448_abnormal_energy_balance | 0.58032399 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypochromic microcytic anemia (HP:0004840) | 5.46268923 |
2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.62770680 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.55342640 |
4 | Intrahepatic cholestasis (HP:0001406) | 4.39468902 |
5 | Hyperglycinuria (HP:0003108) | 4.31711613 |
6 | Abnormality of the intrinsic pathway (HP:0010989) | 3.96740368 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 3.82360503 |
8 | Abnormality of glycine metabolism (HP:0010895) | 3.75216529 |
9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.75216529 |
10 | Hypoglycemic coma (HP:0001325) | 3.70728315 |
11 | Short 1st metacarpal (HP:0010034) | 3.70456778 |
12 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.70456778 |
13 | Pancreatic cysts (HP:0001737) | 3.54788157 |
14 | Xanthomatosis (HP:0000991) | 3.54577330 |
15 | Ketosis (HP:0001946) | 3.53606667 |
16 | Reduced antithrombin III activity (HP:0001976) | 3.45429047 |
17 | Joint hemorrhage (HP:0005261) | 3.42262226 |
18 | Bilateral microphthalmos (HP:0007633) | 3.41311404 |
19 | Ketoacidosis (HP:0001993) | 3.40765161 |
20 | Congenital sensorineural hearing impairment (HP:0008527) | 3.38782251 |
21 | Hyperammonemia (HP:0001987) | 3.34659195 |
22 | Deep venous thrombosis (HP:0002625) | 3.32037018 |
23 | Congenital stationary night blindness (HP:0007642) | 3.28503942 |
24 | Abnormality of the 1st metacarpal (HP:0010009) | 3.18242382 |
25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.13098982 |
26 | Renal cortical cysts (HP:0000803) | 3.11547035 |
27 | Hyperlipoproteinemia (HP:0010980) | 3.11365987 |
28 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.05631061 |
29 | Dicarboxylic aciduria (HP:0003215) | 3.05631061 |
30 | Abnormality of the renal cortex (HP:0011035) | 3.01119517 |
31 | Abnormality of the renal collecting system (HP:0004742) | 3.00859034 |
32 | Pancreatic fibrosis (HP:0100732) | 2.98867354 |
33 | Hepatoblastoma (HP:0002884) | 2.97697040 |
34 | Abnormality of the nasal septum (HP:0000419) | 2.94332259 |
35 | Keratoconus (HP:0000563) | 2.90607744 |
36 | Increased corneal curvature (HP:0100692) | 2.90607744 |
37 | Hyperglycinemia (HP:0002154) | 2.86783593 |
38 | Stenosis of the external auditory canal (HP:0000402) | 2.83955978 |
39 | Abolished electroretinogram (ERG) (HP:0000550) | 2.83561310 |
40 | Hypoglycemic seizures (HP:0002173) | 2.81807892 |
41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.79667570 |
42 | Conjugated hyperbilirubinemia (HP:0002908) | 2.79209129 |
43 | Genetic anticipation (HP:0003743) | 2.78966115 |
44 | True hermaphroditism (HP:0010459) | 2.78873972 |
45 | Nephronophthisis (HP:0000090) | 2.77278625 |
46 | Metabolic acidosis (HP:0001942) | 2.75196482 |
47 | Epidermoid cyst (HP:0200040) | 2.74955134 |
48 | Complement deficiency (HP:0004431) | 2.73838463 |
49 | Hematochezia (HP:0002573) | 2.73795289 |
50 | Hypoplasia of the fovea (HP:0007750) | 2.71750979 |
51 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.71750979 |
52 | Eosinophilia (HP:0001880) | 2.70589655 |
53 | Abnormality of the renal medulla (HP:0100957) | 2.70275392 |
54 | Hypoalphalipoproteinemia (HP:0003233) | 2.68363568 |
55 | Skin nodule (HP:0200036) | 2.67767188 |
56 | Short hallux (HP:0010109) | 2.64820185 |
57 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.59393044 |
58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.57710892 |
59 | Congenital, generalized hypertrichosis (HP:0004540) | 2.55865275 |
60 | Symptomatic seizures (HP:0011145) | 2.55841897 |
61 | Bile duct proliferation (HP:0001408) | 2.53825570 |
62 | Abnormal biliary tract physiology (HP:0012439) | 2.53825570 |
63 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.52193179 |
64 | Decreased central vision (HP:0007663) | 2.51479958 |
65 | Hypobetalipoproteinemia (HP:0003563) | 2.49576309 |
66 | Multiple enchondromatosis (HP:0005701) | 2.48167983 |
67 | Generalized aminoaciduria (HP:0002909) | 2.44781068 |
68 | Abnormality of midbrain morphology (HP:0002418) | 2.44102733 |
69 | Molar tooth sign on MRI (HP:0002419) | 2.44102733 |
70 | Proximal tubulopathy (HP:0000114) | 2.43978715 |
71 | Ragged-red muscle fibers (HP:0003200) | 2.43882127 |
72 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.43415943 |
73 | Hypolipoproteinemia (HP:0010981) | 2.41032639 |
74 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.40818371 |
75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.40502306 |
76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40325897 |
77 | Abnormality of purine metabolism (HP:0004352) | 2.39402146 |
78 | Enlarged kidneys (HP:0000105) | 2.38921843 |
79 | Stomach cancer (HP:0012126) | 2.38186599 |
80 | Abnormality of eosinophils (HP:0001879) | 2.38026960 |
81 | Abnormality of DNA repair (HP:0003254) | 2.37154954 |
82 | Fair hair (HP:0002286) | 2.36570122 |
83 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.35271754 |
84 | Chronic hepatic failure (HP:0100626) | 2.35037000 |
85 | Fat malabsorption (HP:0002630) | 2.35035277 |
86 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.34426782 |
87 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34286058 |
88 | Ectopic kidney (HP:0000086) | 2.34211108 |
89 | Abnormality of alanine metabolism (HP:0010916) | 2.33787200 |
90 | Hyperalaninemia (HP:0003348) | 2.33787200 |
91 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.33787200 |
92 | IgG deficiency (HP:0004315) | 2.33618182 |
93 | Myocardial infarction (HP:0001658) | 2.33537030 |
94 | Hypochromic anemia (HP:0001931) | 2.33426950 |
95 | Carpal bone hypoplasia (HP:0001498) | 2.33030060 |
96 | Anomalous pulmonary venous return (HP:0010772) | 2.32820125 |
97 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.32103035 |
98 | Leukocytosis (HP:0001974) | 2.31759815 |
99 | Thyroiditis (HP:0100646) | 2.31052830 |
100 | Attenuation of retinal blood vessels (HP:0007843) | 2.30492480 |
101 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.30405645 |
102 | Abnormality of methionine metabolism (HP:0010901) | 2.29816779 |
103 | Abnormality of the fovea (HP:0000493) | 2.28460465 |
104 | Abnormality of B cell number (HP:0010975) | 2.28098436 |
105 | Absent/shortened dynein arms (HP:0200106) | 2.27418191 |
106 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.27418191 |
107 | Gingival bleeding (HP:0000225) | 2.27381470 |
108 | Clumsiness (HP:0002312) | 2.24186810 |
109 | Oligomenorrhea (HP:0000876) | 2.22855243 |
110 | Abnormality of the common coagulation pathway (HP:0010990) | 2.21947284 |
111 | Pigmentary retinal degeneration (HP:0001146) | 2.20334223 |
112 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.19546960 |
113 | Short phalanx of the thumb (HP:0009660) | 2.19115396 |
114 | Toxemia of pregnancy (HP:0100603) | 2.18995405 |
115 | Type II lissencephaly (HP:0007260) | 2.16184849 |
116 | Hypercholesterolemia (HP:0003124) | 2.16095473 |
117 | Progressive cerebellar ataxia (HP:0002073) | 2.15712652 |
118 | Gaze-evoked nystagmus (HP:0000640) | 2.15316336 |
119 | Abnormal cartilage morphology (HP:0002763) | 2.14964651 |
120 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.13010151 |
121 | Absent phalangeal crease (HP:0006109) | 2.12140280 |
122 | Decreased circulating renin level (HP:0003351) | 2.11816284 |
123 | Decreased subcutaneous fat (HP:0001002) | 2.11497879 |
124 | Duplicated collecting system (HP:0000081) | 2.10227656 |
125 | Limb hypertonia (HP:0002509) | 2.09586640 |
126 | Agammaglobulinemia (HP:0004432) | 2.09506811 |
127 | Abnormality of nucleobase metabolism (HP:0010932) | 2.09458860 |
128 | Pustule (HP:0200039) | 2.09427549 |
129 | Malnutrition (HP:0004395) | 2.08903114 |
130 | Hyperbilirubinemia (HP:0002904) | 2.08430349 |
131 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.06565783 |
132 | Absent thumb (HP:0009777) | 2.06176084 |
133 | Vomiting (HP:0002013) | 2.05731871 |
134 | Gout (HP:0001997) | 2.05543739 |
135 | Myoglobinuria (HP:0002913) | 2.04265421 |
136 | Generalized hypopigmentation of hair (HP:0011358) | 2.03168359 |
137 | Tubular atrophy (HP:0000092) | 2.03010265 |
138 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.02343326 |
139 | Cystic liver disease (HP:0006706) | 2.01782452 |
140 | Abnormal finger flexion creases (HP:0006143) | 2.01432169 |
141 | Hyperglycemia (HP:0003074) | 2.00697866 |
142 | Combined immunodeficiency (HP:0005387) | 1.99420732 |
143 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.99173532 |
144 | Testicular atrophy (HP:0000029) | 1.98830179 |
145 | Chorioretinal atrophy (HP:0000533) | 1.98646727 |
146 | Granulocytopenia (HP:0001913) | 1.98210177 |
147 | Osteomalacia (HP:0002749) | 1.97682665 |
148 | Pendular nystagmus (HP:0012043) | 1.97580142 |
149 | Pancreatitis (HP:0001733) | 1.97232604 |
150 | Microvesicular hepatic steatosis (HP:0001414) | 1.96973982 |
151 | Fused cervical vertebrae (HP:0002949) | 1.96174980 |
152 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.94920515 |
153 | Partial duplication of thumb phalanx (HP:0009944) | 1.94847766 |
154 | Synostosis of carpal bones (HP:0005048) | 1.94696125 |
155 | Abnormality of the columella (HP:0009929) | 1.93151292 |
156 | Difficulty running (HP:0009046) | 1.92713385 |
157 | Hyperventilation (HP:0002883) | 1.92481710 |
158 | Lethargy (HP:0001254) | 1.91900994 |
159 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.91791870 |
160 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.91791870 |
161 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.91596592 |
162 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91360083 |
163 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91360083 |
164 | Abnormality of the prostate (HP:0008775) | 1.91350210 |
165 | Cheilitis (HP:0100825) | 1.89729906 |
166 | Abnormality of the pulmonary veins (HP:0011718) | 1.89244536 |
167 | Abnormality of proline metabolism (HP:0010907) | 1.88481367 |
168 | Hydroxyprolinuria (HP:0003080) | 1.88481367 |
169 | Morphological abnormality of the middle ear (HP:0008609) | 1.88366366 |
170 | Abnormality of complement system (HP:0005339) | 1.87965264 |
171 | Panhypogammaglobulinemia (HP:0003139) | 1.86305112 |
172 | Prostate neoplasm (HP:0100787) | 1.86275223 |
173 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.85824595 |
174 | Amyloidosis (HP:0011034) | 1.85563830 |
175 | Congenital hepatic fibrosis (HP:0002612) | 1.84764759 |
176 | Stomatitis (HP:0010280) | 1.84633372 |
177 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.82866214 |
178 | Recurrent fungal infections (HP:0002841) | 1.82697807 |
179 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81742127 |
180 | Visual hallucinations (HP:0002367) | 1.80177198 |
181 | Elevated alkaline phosphatase (HP:0003155) | 1.79023659 |
182 | Prolonged bleeding time (HP:0003010) | 1.76882312 |
183 | Albinism (HP:0001022) | 1.76003651 |
184 | Tented upper lip vermilion (HP:0010804) | 1.75991496 |
185 | Increased purine levels (HP:0004368) | 1.74671418 |
186 | Hyperuricemia (HP:0002149) | 1.74671418 |
187 | Abnormal drinking behavior (HP:0030082) | 1.74666421 |
188 | Polydipsia (HP:0001959) | 1.74666421 |
189 | Elevated hepatic transaminases (HP:0002910) | 1.73115728 |
190 | Rib fusion (HP:0000902) | 1.72495309 |
191 | Orchitis (HP:0100796) | 1.72021002 |
192 | Tachypnea (HP:0002789) | 1.71635902 |
193 | Hyperkalemia (HP:0002153) | 1.71520513 |
194 | Medial flaring of the eyebrow (HP:0010747) | 1.70227617 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 4.42451810 |
2 | ERN1 | 3.89167089 |
3 | GRK1 | 3.38845392 |
4 | GRK6 | 2.98332862 |
5 | INSRR | 2.97798623 |
6 | PINK1 | 2.84265148 |
7 | ADRBK2 | 2.80664732 |
8 | GRK5 | 2.80489798 |
9 | TGFBR2 | 2.74291134 |
10 | CSF1R | 2.73401807 |
11 | ACVR1B | 2.64191752 |
12 | BCKDK | 2.28979127 |
13 | MAPK7 | 2.18520229 |
14 | TAOK3 | 2.18225397 |
15 | SIK1 | 2.11500298 |
16 | BMPR1B | 2.03946012 |
17 | GRK7 | 1.99877699 |
18 | FGFR3 | 1.73778387 |
19 | IRAK3 | 1.73294702 |
20 | WNK1 | 1.63762510 |
21 | TLK1 | 1.48523690 |
22 | STK10 | 1.47678115 |
23 | PLK2 | 1.46446725 |
24 | FGFR4 | 1.41716445 |
25 | MATK | 1.40333943 |
26 | WNK4 | 1.38036350 |
27 | MAPK13 | 1.36023075 |
28 | KIT | 1.35984436 |
29 | MAP3K14 | 1.34429541 |
30 | MARK3 | 1.30082983 |
31 | CSK | 1.26467834 |
32 | ITK | 1.26309527 |
33 | TXK | 1.25541682 |
34 | MAP4K2 | 1.22636984 |
35 | HIPK2 | 1.21101272 |
36 | FES | 1.20608363 |
37 | PRKAA2 | 1.20450749 |
38 | CAMK1D | 1.12138285 |
39 | CAMKK2 | 1.10202850 |
40 | EPHB1 | 1.09548971 |
41 | MAP4K1 | 1.08523972 |
42 | FLT3 | 1.08068546 |
43 | MARK2 | 1.06497813 |
44 | MAPK12 | 1.06182829 |
45 | IRAK4 | 1.06182705 |
46 | MOS | 1.03794196 |
47 | MAP2K1 | 1.03139192 |
48 | TEC | 1.02925222 |
49 | DAPK2 | 1.00290879 |
50 | SGK2 | 0.99243281 |
51 | MAP3K7 | 0.97627185 |
52 | TYK2 | 0.97483391 |
53 | MAPK15 | 0.97166523 |
54 | JAK3 | 0.95792928 |
55 | RIPK4 | 0.94490985 |
56 | CAMK4 | 0.94326573 |
57 | TTK | 0.93575276 |
58 | JAK1 | 0.93567822 |
59 | PTK2B | 0.93392732 |
60 | MAPKAPK3 | 0.90611299 |
61 | IRAK1 | 0.88642025 |
62 | MAP2K6 | 0.87601003 |
63 | PIK3CG | 0.87373410 |
64 | IKBKB | 0.83803383 |
65 | PRKG2 | 0.83210840 |
66 | CDK9 | 0.83126804 |
67 | OBSCN | 0.83032622 |
68 | TGFBR1 | 0.82691237 |
69 | ZAK | 0.82342615 |
70 | EIF2AK2 | 0.79870963 |
71 | TIE1 | 0.79462733 |
72 | MAP2K4 | 0.79055198 |
73 | MAP3K13 | 0.78872651 |
74 | PHKG1 | 0.78108440 |
75 | PHKG2 | 0.78108440 |
76 | PKN1 | 0.77670466 |
77 | MAP3K6 | 0.77423163 |
78 | FRK | 0.76903245 |
79 | MAPK11 | 0.76460713 |
80 | EPHA3 | 0.75429772 |
81 | STK38 | 0.74541924 |
82 | NEK2 | 0.72623081 |
83 | NUAK1 | 0.70159574 |
84 | IGF1R | 0.69212403 |
85 | LATS1 | 0.68154224 |
86 | PRKCQ | 0.67039126 |
87 | BTK | 0.65935260 |
88 | STK38L | 0.65742380 |
89 | NLK | 0.64800526 |
90 | MAP3K4 | 0.64269554 |
91 | SGK494 | 0.64036615 |
92 | SGK223 | 0.64036615 |
93 | PRKAA1 | 0.62461357 |
94 | ADRBK1 | 0.61990698 |
95 | ERBB4 | 0.61988360 |
96 | ZAP70 | 0.60890005 |
97 | JAK2 | 0.60677235 |
98 | BMPR2 | 0.60348729 |
99 | IKBKE | 0.59124172 |
100 | WNK3 | 0.58735629 |
101 | CAMK1G | 0.58577410 |
102 | STK39 | 0.58470793 |
103 | PAK3 | 0.58392622 |
104 | SGK3 | 0.58031316 |
105 | PRKCE | 0.58025862 |
106 | CDK7 | 0.57945232 |
107 | MAPK4 | 0.57796007 |
108 | PRKD2 | 0.56951910 |
109 | IRAK2 | 0.55316046 |
110 | CHUK | 0.54317694 |
111 | FGFR2 | 0.53230495 |
112 | RPS6KA6 | 0.52541718 |
113 | RPS6KA5 | 0.50219389 |
114 | MAP2K7 | 0.50092357 |
115 | OXSR1 | 0.49286326 |
116 | STK24 | 0.48925758 |
117 | SGK1 | 0.48395992 |
118 | TYRO3 | 0.48052607 |
119 | SYK | 0.47673051 |
120 | TNIK | 0.46830083 |
121 | LCK | 0.46556296 |
122 | CAMK1 | 0.45475369 |
123 | BLK | 0.44710181 |
124 | STK3 | 0.44440934 |
125 | NEK9 | 0.42721514 |
126 | TNK2 | 0.42284282 |
127 | TRPM7 | 0.41428367 |
128 | PRKACA | 0.40319160 |
129 | PRKG1 | 0.40049949 |
130 | PRKCH | 0.39924457 |
131 | MUSK | 0.39753139 |
132 | LYN | 0.39112109 |
133 | HCK | 0.38992959 |
134 | AKT3 | 0.38194388 |
135 | PRKACG | 0.38025674 |
136 | PIK3CA | 0.36564838 |
137 | PRKCD | 0.34196910 |
138 | CDK3 | 0.33995757 |
139 | CHEK2 | 0.33768975 |
140 | EGFR | 0.33678431 |
141 | GSK3A | 0.33393823 |
142 | ABL1 | 0.32578423 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.21680805 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18269350 |
3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.99149400 |
4 | Asthma_Homo sapiens_hsa05310 | 2.90234339 |
5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.78910680 |
6 | Phototransduction_Homo sapiens_hsa04744 | 2.68065115 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57845687 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50343960 |
9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48139865 |
10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.45380864 |
11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.36165297 |
12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35944345 |
13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.35534307 |
14 | Allograft rejection_Homo sapiens_hsa05330 | 2.32670048 |
15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25057168 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.23152844 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21057150 |
18 | Peroxisome_Homo sapiens_hsa04146 | 2.15583028 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11217641 |
20 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.11083577 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06063322 |
22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01553775 |
23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.98520425 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96332738 |
25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95781237 |
26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93354130 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87859906 |
28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85803859 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85000333 |
30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75441568 |
31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72503524 |
32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.64285283 |
33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.62185402 |
34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.60317205 |
35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.57393869 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56946042 |
37 | ABC transporters_Homo sapiens_hsa02010 | 1.54055846 |
38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.53929613 |
39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.53694223 |
40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.48978399 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42873429 |
42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42188973 |
43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.40145797 |
44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39852029 |
45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39580595 |
46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36018441 |
47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.34965724 |
48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.33188487 |
49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32931888 |
50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32641507 |
51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23889634 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23376638 |
53 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20796177 |
54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18762404 |
55 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13123447 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10043738 |
57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.07724960 |
58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06772092 |
59 | Leishmaniasis_Homo sapiens_hsa05140 | 1.05955855 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 1.03344027 |
61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02406269 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01995450 |
63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00590095 |
64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.96590471 |
65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93497360 |
66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.91751377 |
67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90737749 |
68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90629726 |
69 | Platelet activation_Homo sapiens_hsa04611 | 0.90019530 |
70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89698058 |
71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.87314011 |
72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86600685 |
73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86107617 |
74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86078689 |
75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.85909205 |
76 | Morphine addiction_Homo sapiens_hsa05032 | 0.85868512 |
77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85132612 |
78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81124827 |
79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80848469 |
80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80390143 |
81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80317846 |
82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79081806 |
83 | Salivary secretion_Homo sapiens_hsa04970 | 0.78971812 |
84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76074434 |
85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.76063292 |
86 | Tuberculosis_Homo sapiens_hsa05152 | 0.74315340 |
87 | Bile secretion_Homo sapiens_hsa04976 | 0.72347530 |
88 | Taste transduction_Homo sapiens_hsa04742 | 0.71639022 |
89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71447311 |
90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71378568 |
91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69528747 |
92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69412935 |
93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68632003 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68476067 |
95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67286626 |
96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64746713 |
97 | Renin secretion_Homo sapiens_hsa04924 | 0.63516432 |
98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62343711 |
99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61311707 |
100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61043049 |
101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61022811 |
102 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.59134472 |
103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.58357775 |
104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57147191 |
105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55051782 |
106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53690016 |
107 | Insulin resistance_Homo sapiens_hsa04931 | 0.52574908 |
108 | RNA degradation_Homo sapiens_hsa03018 | 0.52359456 |
109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52180982 |
110 | Homologous recombination_Homo sapiens_hsa03440 | 0.51004843 |
111 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.50523111 |
112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50119185 |
113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48810399 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48221087 |
115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47975963 |
116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.47236581 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45943453 |
118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45894372 |
119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45709250 |
120 | Phagosome_Homo sapiens_hsa04145 | 0.45370028 |
121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.44895401 |
122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44779595 |
123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44623078 |
124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43681785 |
125 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42526920 |
126 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41447608 |
127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40700735 |
128 | Long-term depression_Homo sapiens_hsa04730 | 0.40487504 |
129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39788572 |
130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38174420 |
131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37671900 |
132 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37499519 |
133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34690851 |
134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34629678 |
135 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34199994 |
136 | Protein export_Homo sapiens_hsa03060 | 0.34199328 |
137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33032726 |
138 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31702001 |
139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.31464265 |
140 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30042207 |
141 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27049322 |
142 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26766529 |
143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26223198 |
144 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25763190 |
145 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22119471 |
146 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.19716771 |
147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19651549 |
148 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.15155276 |
149 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.14638332 |
150 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12556804 |